Sensus Healthcare (NASDAQ: SRTS)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sensus Healthcare (NASDAQ: SRTS) through any online brokerage.
Other companies in Sensus Healthcare’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Semler Scientific (NASDAQ:SMLR), Apollo Endosurgery (NASDAQ:APEN) and Lucid Diagnostics (NASDAQ:LUCD).
The latest price target for Sensus Healthcare (NASDAQ: SRTS) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting SRTS to fall to within 12 months (a possible -73.28% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Sensus Healthcare (NASDAQ: SRTS) is $14.97 last updated August 12, 2022, 8:00 PM UTC.
The next Sensus Healthcare (SRTS) dividend date is projected to be Thursday, September 1, 2022.
Sensus Healthcare’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Sensus Healthcare.
Sensus Healthcare is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.